Detalles de la búsqueda
1.
Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Breast Cancer Res Treat
; 203(2): 225-234, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875670
2.
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial).
Breast Cancer Res Treat
; 199(2): 253-263, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000345
3.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405087
4.
Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique.
Surg Today
; 51(6): 862-871, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185799
5.
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.
Cancer Sci
; 111(8): 2760-2769, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495455
6.
Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expression.
Histopathology
; 76(4): 560-571, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31554015
7.
[Triple-Tracer Technique of Sentinel Lymph Node Biopsy Using Blue Dye plus Radioisotope Combined with Real-Time Indocyanine Green(ICG)Fluorescence Imaging Procedures for Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy].
Gan To Kagaku Ryoho
; 47(8): 1225-1227, 2020 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-32829360
8.
Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer.
Hell J Nucl Med
; 21(1): 35-42, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550845
9.
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.
Cancer Sci
; 108(1): 81-90, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27801993
10.
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.
Cancer Sci
; 108(4): 598-603, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28178396
11.
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
Oncology
; 93(1): 51-61, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28478451
12.
[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment].
Gan To Kagaku Ryoho
; 43(10): 1249-1251, 2016 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-27760950
13.
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
Cancer Sci
; 106(10): 1257-63, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26212219
14.
Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case.
Surg Today
; 45(1): 115-20, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24395027
15.
[Pretreatment and Posttreatment Evaluations of Circulating Tumor Cellsï¼CTCï¼in Patients with Metastatic Breast Cancer].
Gan To Kagaku Ryoho
; 42(10): 1237-9, 2015 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-26489558
16.
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.
Breast Cancer Res
; 16(4): R70, 2014 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24992895
17.
Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Jpn J Clin Oncol
; 44(9): 876-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25030214
18.
Usefulness of endoscopic breast-conserving surgery for breast cancer.
Surg Today
; 44(11): 2037-44, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24150099
19.
Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Eur J Prev Cardiol
; 30(18): 1941-1949, 2023 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352112
20.
Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways.
J Cell Biochem
; 113(7): 2346-55, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22359269